Gene · 2192
Papers1,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Manipulating host secreted protein gene expression: an indirect approach by HPV11/16 E6/E7 to suppress PBMC cytokine secretion. | Virol J | 2024 | 39095779 | PubTator, text mining | PubMed |
| The Impact of Acute EBV Infection on Changes in the Serum Proteome in Children-A Pilot Study. | Pathogens | 2024 | 38921769 | PubTator, text mining | PubMed |
| Identification of potential shared gene signatures between gastric cancer and type 2 diabetes: a data-driven analysis. | Front Med (Lausanne) | 2024 | 38903804 | PubTator, text mining | PubMed |
| Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD. | Hepatol Commun | 2024 | 38829196 | PubTator, text mining | PubMed |
| Association between CTX-1 and Fibulin-1 Serum Levels with Pathogenesis of Multiple Myeloma Cancer. | Asian Pac J Cancer Prev | 2024 | 38809631 | PubTator, text mining | PubMed |
| Electrospun poly(l-lactide-co-dl-lactide) nanofibrous scaffold as substrate for ex vivo limbal epithelial cell cultivation. | Heliyon | 2024 | 38803982 | PubTator, text mining | PubMed |
| Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery. | Theranostics | 2024 | 38773973 | PubTator, text mining | PubMed |
| Multiomics Analysis Unravels Alteration in Molecule and Pathways Involved in Nondiabetic Chronic Wounds. | ACS Omega | 2024 | 38737053 | PubTator, text mining | PubMed |
| Epigenome-wide association study identifies DNA methylation loci associated with handgrip strength in Chinese monozygotic twins. | Front Cell Dev Biol | 2024 | 38633108 | PubTator, text mining | PubMed |
| Fibulin-1 promotes intimal hyperplasia after venous stent implantation through ACE mediated angiotensin II signaling. | Heliyon | 2024 | 38560238 | PubTator, text mining | PubMed |
| miR615-3p inhibited FBLN1 and osteogenic differentiation of umbilical cord mesenchymal stem cells by associated with YTHDF2 in a m6A-miRNA interaction manner. | Cell Prolif | 2024 | 38353178 | PubTator, text mining | PubMed |
| Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics. | iScience | 2024 | 38303703 | PubTator, text mining | PubMed |
| Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer. | Nat Commun | 2024 | 38302471 | PubTator, text mining | PubMed |
| Uveitic glaucoma-like features in Yap conditional knockout mice. | Cell Death Discov | 2024 | 38272861 | PubTator, text mining | PubMed |
| Proteomic insights into mental health status: plasma markers in young adults. | Transl Psychiatry | 2024 | 38267423 | PubTator, text mining | PubMed |
| FBLN5 as One Presumably Prognostic Gene Potentially Modulating Tumor Immune Microenvironment for Renal Clear Cell Carcinoma in Children and Young Adults. | Pharmgenomics Pers Med | 2024 | 38264064 | PubTator, text mining | PubMed |
| Modulation of Extracellular Matrix Composition and Chronic Inflammation with Pirfenidone Promotes Scar Reduction in Retinal Wound Repair. | Cells | 2024 | 38247855 | PubTator, text mining | PubMed |
| Secretomics reveals hormone-therapy of breast cancer may induce survival by facilitating hypercoagulation and immunomodulation in vitro. | Sci Rep | 2024 | 38233507 | PubTator, text mining | PubMed |
| Analyzing secretory proteins in human dermal fibroblast-conditioned medium for angiogenesis: A bioinformatic approach. | Skin Res Technol | 2024 | 38200622 | PubTator, text mining | PubMed |
| Serum multi-omics analysis in hindlimb unloading mice model: Insights into systemic molecular changes and potential diagnostic and therapeutic biomarkers. | Heliyon | 2024 | 38187258 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2192/papers?page=5